⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

GMAB News

Genmab A/S ADS

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S ®) in Advanced Endometrial Cancer (EC)